An independent resource on ibogaine, depression, evidence, and safety.
Mainspring exists to help readers evaluate what is known, unknown, and overstated about explorations into ibogaine and depressive symptoms. Our work emphasizes clear summaries of evidence, the limits of current research, and safety considerations so people and professionals can make better-informed decisions. For a concise orientation to our site structure, see the editorial overview on the homepage and our services description within the site's navigation.
Our mission is simple: present evidence, regulatory context, and safety considerations in clear language. We avoid promotional claims and aim to show uncertainty where it exists so readers can weigh risks and benefits themselves. When we say "evidence", we mean peer-reviewed literature, registries, and official guidance rather than anecdote alone.
We prioritize primary sources: clinical trial reports, registry data, and regulatory statements. Where useful, we reference authoritative overviews such as reviews on Wikipedia and guidance from recognized institutions to contextualize methodology and risk; for example, methodological norms are described broadly on Systematic review (Wikipedia) and trial registration best practices are discussed by major research registries.
We publish topical summaries, methodological notes, and interpretive guides that explain how studies were conducted and what conclusions are reasonable from available data. Coverage includes summaries of clinical evidence, cost and access considerations, and regulatory signals, arranged so that readers can find high-level takeaways alongside links to source documents and service descriptions. Where relevant to understanding systems of care and regulation, we link to authoritative sources such as the U.S. National Library of Medicine for trial records (National Library of Medicine).
Because readers sometimes seek operational context, we also provide inline links to informational pages about service models and cost contexts; for example, some visitors review clinic-adjacent resources like pricing contexts in Mexico while others consult analyses of veteran-focused programs such as information shared on veterans' treatment pages.
Content is created by editors who summarize peer-reviewed findings and cross-check claims against registry entries, trial reports, and government guidance. For assertions about safety and pharmacology we reference recognized sources such as university reviews or public health pages when appropriate; for example, methodological expectations align with guidance available from university research offices and registries like Clinical trial (Wikipedia) and official registries such as ClinicalTrials.gov (ClinicalTrials.gov).
We weave links to original reports, registry entries, and authoritative overviews directly into prose so readers can follow the evidence trail. We also include contextual internal links to pages that describe services and evidence synthesis; for example, readers can navigate from this about page into our services descriptions or return to the site's overview via the homepage's opening material (site homepage overview).
Throughout our coverage we sometimes link to topic-adjacent resources that help readers understand cost, access, and service models. Examples include informational sites addressing treatment costs such as international cost comparisons and therapy-specific portals like PTSD-focused ibogaine therapy discussions. These links are provided for context, not endorsement.
We welcome careful scrutiny of our summaries. If you would like to point out corrections or offer source suggestions, see our contact page for the appropriate channel. Remember: this resource is informational and independent; it is not a substitute for professional medical advice.
